ModGRF 1-29 + Ipamorelin (5/5 mg) is a synthetic peptide combination frequently used in scientific and clinical research to study the endocrine system, particularly focusing on growth hormone (GH) regulation and release.
🧬 What is ModGRF 1-29?
Also known as CJC-1295 without DAC, ModGRF 1-29 is a modified version of growth hormone-releasing hormone (GHRH).
It stimulates the pituitary gland to produce and release GH.
The modification helps it act more effectively and last longer in the bloodstream compared to natural GHRH.
🧠What is Ipamorelin?
Ipamorelin is a selective growth hormone secretagogue (GHS), which mimics ghrelin, the 'hunger hormone.'
It binds to the ghrelin receptor (GHS-R1a), causing the pituitary to release additional GH without significantly increasing cortisol or prolactin—unlike some older peptides.
đź’‰ Combined Formulation (5/5 mg)
This formulation includes:
5 mg of ModGRF 1-29
5 mg of Ipamorelin
Typically provided in lyophilized powder form, meant to be reconstituted with bacteriostatic water for research administration.
🧪 Research Applications
This peptide blend is utilized in scientific studies to:
Stimulate Growth Hormone Release: Mod GRF 1-29 acts as a GHRH analog, while Ipamorelin mimics ghrelin, both promoting GH secretion.
Study GH Dynamics: Investigate the pulsatile release patterns and regulation of growth hormone.
Explore Metabolic Effects: Assess impacts on muscle growth, fat metabolism, and bone density.
Evaluate Sleep and Recovery: Examine effects on sleep quality and tissue repair processes.
Keywords
modgrf 129
scientific studies
pituitary gland
dac modgrf 129
sleep quality
ghrh analog
peptide blend
bacteriostatic water
hunger hormone
natural ghrh
bloodstream compared
modification helps
modified version
endocrine system
clinical research
release gh
mimics ghrelin
ipamorelin ipamorelin
ipamorelin mimics ghrelin
release additional gh
pulsatile release patterns
ipamorelin typically provided
tissue repair processes
recovery examine effects
significantly increasing cortisol
